Specificity of Prohormone Convertase 2 on Proenkephalin and Proenkephalin-related Substrates*

In the central and peripheral nervous systems, the neuropeptide precursor proenkephalin must be endoproteolytically cleaved by enzymes known as prohormone convertases 1 and 2 (PC1 and PC2) to generate opioid-active enkephalins. In this study, we have investigated the specificity of recombinant mouse PC2 for proenkephalin-related internally quenched (IQ) peptides, for methylcoumarin amide-based fluorogenic peptides, and for recombinant rat proenkephalin. IQ peptides exhibited specificity constants (k cat/K m ) between 9.4 × 104 m −1 s−1(Abz-Val-Pro-Arg-Met-Glu-Lys-Arg-Tyr-Gly-Gly-Phe-Met-Gln-EDDnp; where Abz is οrtho-aminobenzoic acid and EDDnp isN-(2,4-dinitrophenyl)ethylenediamine)) and 0.24 × 104 m −1 s−1(Abz-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-EDDnp), with the peptide B to Met-enk-Arg-Phe cleavage preferred (Met-enk is met-enkephalin). Fluorogenic substrates with P1, P2, and P4 basic amino acids were hydrolyzed with specificity constants ranging between 2.0 × 103 m −1s−1 (Ac-Orn-Ser-Lys-Arg-MCA; where MCA is methylcoumarin amide) and 1.8 × 104 m −1s−1 (<Glu-Arg-Thr-Lys-Arg-MCA; where <Glu is pyroglutamic acid). Substrates containing only a single basic residue were not appreciably hydrolyzed, and substrates lacking a P4 Arg exhibited k cat of less than 0.05 s−1. Substitution of ornithine for Lys at the P4 position did not significantly affect the k cat but increased the K m 2-fold. Data from both sets of fluorogenic substrates supported the contribution of a P4 Arg to PC2 preference. Analysis of proenkephalin reaction products using immunoblotting and gel permeation chromatography demonstrated that PC2 can directly cleave proenkephalin and that the generation of small opioid peptides from intermediates is mediated almost entirely by PC2 rather than by PC1. These results are in accord with the analysis of PC2 knock-out brains, in which the amounts of three mature enkephalins were depleted by more than three-quarters.

[1]  N. Seidah,et al.  In Vitro Cleavage of Internally Quenched Fluorogenic Human Proparathyroid Hormone and Proparathyroid-related Peptide Substrates by Furin , 1998, The Journal of Biological Chemistry.

[2]  I. Lindberg,et al.  Prodynorphin Processing by Proprotein Convertase 2 , 1998, The Journal of Biological Chemistry.

[3]  M L Agarwal,et al.  The p53 Network* , 1998, The Journal of Biological Chemistry.

[4]  B. Rist,et al.  Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. , 1997, Biochemistry.

[5]  P. Halban,et al.  Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon , 1997, FEBS letters.

[6]  L. Orci,et al.  Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Scharfstein,et al.  Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides. , 1997, The Biochemical journal.

[8]  G. Krafft,et al.  Internally consistent libraries of fluorogenic substrates demonstrate that Kex2 protease specificity is generated by multiple mechanisms. , 1997, Biochemistry.

[9]  M. Beinfeld,et al.  Cleavage of CCK 33 by recombinant PC2 in vitro. , 1997, Biochemical and biophysical research communications.

[10]  I. Lindberg,et al.  Processing Site Blockade Results in More Efficient Conversion of Proenkephalin to Active Opioid Peptides* , 1996, The Journal of Biological Chemistry.

[11]  S. Brennan,et al.  The specificity of the neuroendocrine convertase PC3 is determined by residues NH2‐ and COOH‐terminal to the cleavage site , 1996, Biochemistry and molecular biology international.

[12]  I. Lindberg,et al.  Purification and enzymatic characterization of recombinant prohormone convertase 2: stabilization of activity by 21 kDa 7B2. , 1996, Archives of biochemistry and biophysics.

[13]  M. Schiller,et al.  The processing proteases prohormone thiol protease, PC1/3 and PC2, and 70-kDa aspartic proteinase show preferences among proenkephalin, proneuropeptide Y, and proopiomelanocortin substrates. , 1996, Archives of biochemistry and biophysics.

[14]  I. Lindberg,et al.  Role of PC2 in Proenkephalin Processing: Antisense and Overexpression Studies , 1996, Journal of neurochemistry.

[15]  N. Seidah,et al.  Peptidyl substrates containing unnatural amino acid at the P'1 position are potent inhibitors of prohormone convertases. , 2009, International journal of peptide and protein research.

[16]  Y. Loh,et al.  Pro‐Thyrotropin‐Releasing Hormone Processing by Recombinant PC1 , 1995, Journal of neurochemistry.

[17]  D. Steiner,et al.  Proteolytic Processing Mechanisms in the Biosynthesis of Neuroendocrine Peptides: The Subtilisin-like Proprotein Convertases , 1995, Frontiers in Neuroendocrinology.

[18]  N. Seidah,et al.  Fluorescent Peptidyl Substrates as an Aid in Studying the Substrate Specificity of Human Prohormone Convertase PC1 and Human Furin and Designing a Potent Irreversible Inhibitor (*) , 1995, The Journal of Biological Chemistry.

[19]  K. Docherty,et al.  Differences between the catalytic properties of recombinant human PC2 and endogenous rat PC2. , 1995, The Biochemical journal.

[20]  N. Seidah,et al.  An internally quenched fluorogenic substrate of prohormone convertase 1 and furin leads to a potent prohormone convertase inhibitor. , 1995, The Biochemical journal.

[21]  I. Lindberg,et al.  Processing of Mouse Proglucagon by Recombinant Prohormone Convertase 1 and Immunopurified Prohormone Convertase 2 in Vitro(*) , 1995, The Journal of Biological Chemistry.

[22]  G. Thomas,et al.  Internally quenched fluorogenic substrate for furin. , 1995, Analytical biochemistry.

[23]  Y. Loh,et al.  In vitro processing of anthrax toxin protective antigen by recombinant PC1 (SPC3) and bovine intermediate lobe secretory vesicle membranes. , 1995, Archives of biochemistry and biophysics.

[24]  Y. Loh,et al.  In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3). , 1994, Endocrinology.

[25]  C. Gorman,et al.  A survey of furin substrate specificity using substrate phage display , 1994, Protein science : a publication of the Protein Society.

[26]  I. Lindberg,et al.  Enzymatic properties of carboxyl-terminally truncated prohormone convertase 1 (PC1/SPC3) and evidence for autocatalytic conversion. , 1994, The Journal of biological chemistry.

[27]  R. Mains,et al.  Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. , 1994, The Journal of biological chemistry.

[28]  R. Siezen,et al.  Homology modelling of the catalytic domain of human furin. A model for the eukaryotic subtilisin-like proprotein convertases. , 1994, European journal of biochemistry.

[29]  K. Docherty,et al.  Autocatalytic maturation of the prohormone convertase PC2. , 1994, The Journal of biological chemistry.

[30]  H. Akil,et al.  Processing of prodynorphin by the prohormone convertase PC1 results in high molecular weight intermediate forms , 1994, FEBS letters.

[31]  A. Roebroek,et al.  Furin-mediated proprotein processing activity: involvement of negatively charged amino acid residues in the substrate binding region. , 1994, Biochimie.

[32]  N. Seidah,et al.  Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin. , 1993, The Journal of biological chemistry.

[33]  J. Dixon,et al.  Purification and characterization of the candidate prohormone-processing enzyme SPC3 produced in a mouse L cell line. , 1993, The Journal of biological chemistry.

[34]  N. Seidah,et al.  Enzymic characterization of murine and human prohormone convertase-1 (mPC1 and hPC1) expressed in mammalian GH4C1 cells. , 1993, The Biochemical journal.

[35]  M. Rholam,et al.  Role of beta-turn in proteolytic processing of peptide hormone precursors at dibasic sites. , 1993, Biochemistry.

[36]  I. Lindberg,et al.  Purification and characterization of the prohormone convertase PC1(PC3). , 1993, The Journal of biological chemistry.

[37]  I. Lindberg,et al.  Posttranslational processing of proenkephalin in AtT-20 cells: evidence for cleavage at a Lys-Lys site. , 1992, Endocrinology.

[38]  S. Takahashi,et al.  Purification and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells. , 1992, The Journal of biological chemistry.

[39]  R. Leduc,et al.  Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. , 1992, The Journal of biological chemistry.

[40]  I. Lindberg,et al.  Posttranslational Processing of Proenkephalin in SK‐N‐MC Cells: Evidence for Phosphorylation , 1992, Journal of neurochemistry.

[41]  C. Brenner,et al.  Structural and enzymatic characterization of a purified prohormone-processing enzyme: secreted, soluble Kex2 protease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Christie,et al.  Identification of kex2-related proteases in chromaffin granules by partial amino acid sequence analysis. , 1991, The Journal of biological chemistry.

[43]  I. Lindberg,et al.  Posttranslational modifications of rat proenkephalin overexpressed in Chinese hamster ovary cells. , 1991, Endocrinology.

[44]  M Chrétien,et al.  cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases. , 1990, DNA and cell biology.

[45]  R. Mains,et al.  Cellular and molecular aspects of peptide hormone biosynthesis , 1990 .

[46]  I. Lindberg,et al.  Cleavage of proenkephalin by a chromaffin granule processing enzyme. , 1990, Endocrinology.

[47]  I. Lindberg,et al.  Distribution of immunoreactive peptide B in the rat brain. , 1986, Biochemical and biophysical research communications.

[48]  D. Christie,et al.  Characterization of the molecular forms of proenkephalin in bovine adrenal medulla and rat adrenal, brain, and spinal cord with a site-directed antiserum. , 1986, The Journal of biological chemistry.

[49]  J. P. Schwartz,et al.  A reduction of the tone of 5-hydroxytryptamine neurons decreases utilization rates of striatal and hypothalamic enkephalins. , 1984, European journal of pharmacology.

[50]  I. Lindberg,et al.  Distribution of met5-enkephalin-arg6-gly7-leu8-immunoreactive peptides in rat brain: Presence of multiple molecular forms , 1984, Brain Research.

[51]  W. Hancock,et al.  Antisera to synthetic peptide recognize high molecular weight enkephalin-containing proteins. , 1984, Biochemical and biophysical research communications.

[52]  S. Udenfriend,et al.  Biochemistry of the enkephalins and enkephalin-containing peptides. , 1983, Archives of biochemistry and biophysics.

[53]  P. Giraud,et al.  Enkephalins, ACTH, α-MSH and β-endorphin in human pheochromocytomas , 1981, Neuropeptides.